C007:F:F-Lyxor MDAX® (DR) UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 22.54

Change

-0.01 (-0.04)%

Market Cap

USD 0.18B

Volume

5.34K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.03 (-0.09%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.05 (+0.10%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+0.60 (+0.25%)

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.05B
VUSA:F Vanguard Funds Public Limited ..

+0.24 (+0.24%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.28 (+0.28%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.74B
0ZC:F Zscaler Inc

-3.78 (-2.48%)

USD 37.92B

ETFs Containing C007:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.93% 13% F 38% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.93% 11% F 33% F
Trailing 12 Months  
Capital Gain 0.92% 17% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.92% 15% F 35% F
Trailing 5 Years  
Capital Gain -3.26% 26% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.26% 26% F 29% F
Average Annual (5 Year Horizon)  
Capital Gain 0.68% N/A N/A 47% F
Dividend Return 0.68% N/A N/A 41% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.84% N/A N/A 64% D
Risk Adjusted Return 3.41% N/A N/A 41% F
Market Capitalization 0.18B 38% F 38% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.